Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells

The accurate estimation and eradication of Human Immunodeficiency Virus (HIV) viral reservoirs is limited by the incomplete reactivation of cells harboring the latent replication-competent virus. We investigated whether the in vitro and in vivo addition of retinoic acid (RA) enhances virus replicati...

Full description

Bibliographic Details
Main Authors: Omalla A. Olwenyi, Arpan Acharya, Nanda Kishore Routhu, Keely Pierzchalski, Jace W. Jones, Maureen A. Kane, Neil Sidell, Mahesh Mohan, Siddappa N. Byrareddy
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/9/2076
_version_ 1827706436911628288
author Omalla A. Olwenyi
Arpan Acharya
Nanda Kishore Routhu
Keely Pierzchalski
Jace W. Jones
Maureen A. Kane
Neil Sidell
Mahesh Mohan
Siddappa N. Byrareddy
author_facet Omalla A. Olwenyi
Arpan Acharya
Nanda Kishore Routhu
Keely Pierzchalski
Jace W. Jones
Maureen A. Kane
Neil Sidell
Mahesh Mohan
Siddappa N. Byrareddy
author_sort Omalla A. Olwenyi
collection DOAJ
description The accurate estimation and eradication of Human Immunodeficiency Virus (HIV) viral reservoirs is limited by the incomplete reactivation of cells harboring the latent replication-competent virus. We investigated whether the in vitro and in vivo addition of retinoic acid (RA) enhances virus replication and improves the detection of latent virus. Peripheral blood mononuclear cells (PBMCs) from naive and anti-retroviral therapy (ART)-treated SIV-infected rhesus macaques (RMs) were cultured in vitro with anti-CD3/CD28 + IL-2 in the presence/absence of RA. Viral RNA and p27 levels were quantified using RT-qPCR and ELISA, respectively. Viral reservoirs were estimated using the Tat/Rev-Induced Limited Dilution Assay (TILDA) and Quantitative Viral Outgrowth Assay (QVOA). In vitro and in vivo measures revealed that there was also an increase in viral replication in RA-treated versus without RA conditions. In parallel, the addition of RA to either CD3/CD28 or phorbol myristate acetate (PMA)/ionomycin during QVOA and TILDA, respectively, was shown to augment reactivation of the replication-competent viral reservoir in anti-retroviral therapy (ART)-suppressed RMs as shown by a greater than 2.3-fold increase for QVOA and 1 to 2-fold increments for multi-spliced RNA per million CD4<sup>+</sup> T cells. The use of RA can be a useful approach to enhance the efficiency of current protocols used for in vitro and potentially in vivo estimates of CD4<sup>+</sup> T cell latent reservoirs. In addition, flow cytometry analysis revealed that RA improved estimates of various viral reservoir assays by eliciting broad CD4 T-cell activation as demonstrated by elevated CD25 and CD38 but reduced CD69 and PD-1 expressing cells.
first_indexed 2024-03-10T16:24:21Z
format Article
id doaj.art-4dcf15b9930a4d39ae3e2c00fca3efc0
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T16:24:21Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-4dcf15b9930a4d39ae3e2c00fca3efc02023-11-20T13:21:11ZengMDPI AGCells2073-44092020-09-0199207610.3390/cells9092076Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected CellsOmalla A. Olwenyi0Arpan Acharya1Nanda Kishore Routhu2Keely Pierzchalski3Jace W. Jones4Maureen A. Kane5Neil Sidell6Mahesh Mohan7Siddappa N. Byrareddy8Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USADepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USADepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USADepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USADepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USADepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USADepartment of Obstetrics and Gynecology, Emory University School of Medicine, Atlanta, GA 30322, USATexas Biomedical Research Institute, Southwest National Primate Research Institute, San Antonio, TX 78227, USADepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USAThe accurate estimation and eradication of Human Immunodeficiency Virus (HIV) viral reservoirs is limited by the incomplete reactivation of cells harboring the latent replication-competent virus. We investigated whether the in vitro and in vivo addition of retinoic acid (RA) enhances virus replication and improves the detection of latent virus. Peripheral blood mononuclear cells (PBMCs) from naive and anti-retroviral therapy (ART)-treated SIV-infected rhesus macaques (RMs) were cultured in vitro with anti-CD3/CD28 + IL-2 in the presence/absence of RA. Viral RNA and p27 levels were quantified using RT-qPCR and ELISA, respectively. Viral reservoirs were estimated using the Tat/Rev-Induced Limited Dilution Assay (TILDA) and Quantitative Viral Outgrowth Assay (QVOA). In vitro and in vivo measures revealed that there was also an increase in viral replication in RA-treated versus without RA conditions. In parallel, the addition of RA to either CD3/CD28 or phorbol myristate acetate (PMA)/ionomycin during QVOA and TILDA, respectively, was shown to augment reactivation of the replication-competent viral reservoir in anti-retroviral therapy (ART)-suppressed RMs as shown by a greater than 2.3-fold increase for QVOA and 1 to 2-fold increments for multi-spliced RNA per million CD4<sup>+</sup> T cells. The use of RA can be a useful approach to enhance the efficiency of current protocols used for in vitro and potentially in vivo estimates of CD4<sup>+</sup> T cell latent reservoirs. In addition, flow cytometry analysis revealed that RA improved estimates of various viral reservoir assays by eliciting broad CD4 T-cell activation as demonstrated by elevated CD25 and CD38 but reduced CD69 and PD-1 expressing cells.https://www.mdpi.com/2073-4409/9/9/2076immune activationretinoic acidCD4 T cellsPBMCsSIVviral load and provirus
spellingShingle Omalla A. Olwenyi
Arpan Acharya
Nanda Kishore Routhu
Keely Pierzchalski
Jace W. Jones
Maureen A. Kane
Neil Sidell
Mahesh Mohan
Siddappa N. Byrareddy
Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
Cells
immune activation
retinoic acid
CD4 T cells
PBMCs
SIV
viral load and provirus
title Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
title_full Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
title_fullStr Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
title_full_unstemmed Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
title_short Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
title_sort retinoic acid improves the recovery of replication competent virus from latent siv infected cells
topic immune activation
retinoic acid
CD4 T cells
PBMCs
SIV
viral load and provirus
url https://www.mdpi.com/2073-4409/9/9/2076
work_keys_str_mv AT omallaaolwenyi retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT arpanacharya retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT nandakishorerouthu retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT keelypierzchalski retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT jacewjones retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT maureenakane retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT neilsidell retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT maheshmohan retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells
AT siddappanbyrareddy retinoicacidimprovestherecoveryofreplicationcompetentvirusfromlatentsivinfectedcells